Maso Capital Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Maso Capital Partners’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100,000	Closed	-$132K	–	27
2023 Q3	$132K	Hold	100,000	–	–	0.07%	27
2023 Q2	$299K	Hold	100,000	–	–	0.13%	27
2023 Q1	$346K	Hold	100,000	–	–	0.23%	26
2022 Q4	$418K	Hold	100,000	–	–	0.15%	28
2022 Q3	$401K	Hold	100,000	–	–	0.09%	38
2022 Q2	$1.13M	Buy	+100,000	New	+$1.2M	0.64%	34

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Maso Capital Partners's NBP Position: Q4 2023 in Review

Maso Capital Partners sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2023, closing a stake of 100,000 shares — an estimated $132K sold.

Maso Capital Partners first reported a position in NBP in Q2 2022 and held it in 6 quarters. The position peaked at $1.13M in Q2 2022. 44 funds tracked by Wall St. Rank hold NBP as of Q4 2023.

Maso Capital Partners reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Maso Capital Partners sold 100,000 NovaBridge Biosciences American Depositary Shares shares in Q4 2023, an estimated $132K.
Maso Capital Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2022 and held it in 6 quarters.
Maso Capital Partners's NovaBridge Biosciences American Depositary Shares position peaked at $1.13M in Q2 2022.
44 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2023.

Based on Maso Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.